-
1
-
-
20444497652
-
Psoriasis - Recent advances in understanding its pathogenesis and treatment
-
DOI 10.1016/j.jaad.2005.04.035, PII S0190962205013137, New Strategies for Optimizing the Treatment of Inflamatory Dermatoses with Topical Corticosteroids in an Era of Costisosteroids-Sparing
-
Krueger G, Ellis CN. Psoriasis - recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 2005; 53: S94-S100. (Pubitemid 40828186)
-
(2005)
Journal of the American Academy of Dermatology
, vol.53
, Issue.1 SUPPL.
-
-
Krueger, G.1
Ellis, C.N.2
-
2
-
-
34447539622
-
Pathogenesis and clinical features of psoriasis
-
Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-271.
-
(2007)
Lancet
, vol.370
, pp. 263-271
-
-
Griffiths, C.E.1
Barker, J.N.2
-
3
-
-
59649105640
-
Interplay between keratinocytes and immune cells - Recent insights into psoriasis pathogenesis
-
Tonel G, Conrad C. Interplay between keratinocytes and immune cells - recent insights into psoriasis pathogenesis. Int J Biochem Cell Biol 2009; 41: 963-968.
-
(2009)
Int J Biochem Cell Biol
, vol.41
, pp. 963-968
-
-
Tonel, G.1
Conrad, C.2
-
4
-
-
33847279025
-
Pathogenesis and therapy of psoriasis
-
Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
-
(2007)
Nature
, vol.445
, pp. 866-873
-
-
Lowes, M.A.1
Bowcock, A.M.2
Krueger, J.G.3
-
5
-
-
36749053497
-
Psoriasis: Advances in pathophysiology and management
-
MacDonald A, Burden AD. Psoriasis: advances in pathophysiology and management. Postgrad Med 2007; 83: 690-697.
-
(2007)
Postgrad Med
, vol.83
, pp. 690-697
-
-
MacDonald, A.1
Burden, A.D.2
-
7
-
-
0035954670
-
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
-
Ellis CN, Krueger GG. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 2001; 345: 248-255.
-
(2001)
N Engl J Med
, vol.345
, pp. 248-255
-
-
Ellis, C.N.1
Krueger, G.G.2
-
8
-
-
0043135118
-
Development and use of alefacept to treat psoriasis
-
Krueger GG, Callis KP. Development and use of alefacept to treat psoriasis. J Am Acad Dermatol 2003; 49: S87-S97.
-
(2003)
J Am Acad Dermatol
, vol.49
-
-
Krueger, G.G.1
Callis, K.P.2
-
10
-
-
0012948856
-
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histologic, immunohistologic, and molecular biology findings
-
Asadullah K, Friedrich M, Hanneken S, et al. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 2001; 116: 721-727.
-
(2001)
J Invest Dermatol
, vol.116
, pp. 721-727
-
-
Asadullah, K.1
Friedrich, M.2
Hanneken, S.3
-
11
-
-
0032519956
-
IL-10 is a key cytokine in psoriasis. Proof principle by IL-10 therapy: A new therapeutic approach
-
Asadullah K, Sterry W, Stephamek K, et al. IL-10 is a key cytokine in psoriasis. Proof principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998; 101: 783-794.
-
(1998)
J Clin Invest
, vol.101
, pp. 783-794
-
-
Asadullah, K.1
Sterry, W.2
Stephamek, K.3
-
13
-
-
0043135095
-
Infliximab for psoriasis
-
Gottlieb AB. Infliximab for psoriasis. J Am Acad Dermatol 2003; 49: S112-S117.
-
(2003)
J Am Acad Dermatol
, vol.49
-
-
Gottlieb, A.B.1
-
14
-
-
6344286067
-
Adalimumab: Efficacy and safety in psoriasis and rheumatoid arthritis
-
Patel T, Gordon KB. Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis. Dermatol Ther 2004; 17: 427-431.
-
(2004)
Dermatol Ther
, vol.17
, pp. 427-431
-
-
Patel, T.1
Gordon, K.B.2
-
15
-
-
0035832515
-
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial
-
Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb P. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001; 357: 1842-1847.
-
(2001)
Lancet
, vol.357
, pp. 1842-1847
-
-
Chaudhari, U.1
Romano, P.2
Mulcahy, L.D.3
Dooley, L.T.4
Baker, D.G.5
Gottlieb, P.6
-
16
-
-
0037234390
-
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
-
Ghoreschi K, Thomas P, Breit S, et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-46.
-
(2003)
Nat Med
, vol.9
, pp. 40-46
-
-
Ghoreschi, K.1
Thomas, P.2
Breit, S.3
-
18
-
-
0038644624
-
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis
-
DOI 10.1182/blood-2002-12-3793
-
Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003; 102: 161-168. (Pubitemid 36759650)
-
(2003)
Blood
, vol.102
, Issue.1
, pp. 161-168
-
-
Xia, Y.-P.1
Li, B.2
Hylton, D.3
Detmar, M.4
Yancopoulos, G.D.5
Rudge, J.S.6
-
21
-
-
0025905569
-
Overview and evolution of therapeutic systems
-
Zaffaroni A. Overview and evolution of therapeutic systems. Ann NY Acad Sci 1991; 618: 405-421.
-
(1991)
Ann NY Acad Sci
, vol.618
, pp. 405-421
-
-
Zaffaroni, A.1
-
22
-
-
0742288421
-
Discovery of transdermal penetration enhancers by high-throughput screening
-
KarandeP, JainA, MitragotriS. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 2004; 22: 192-197.
-
(2004)
Nat Biotechnol
, vol.22
, pp. 192-197
-
-
Karande, P.1
Jain, A.2
Mitragotri, S.3
-
23
-
-
0033052792
-
Topical gene delivery to murine skin
-
Yu WH, Kashani-Sabet M, Liggitt D, Moore D, Heath TD, Debs RJ. Topical gene delivery to murine skin. J Invest Dermatol 1999; 112: 370-375.
-
(1999)
J Invest Dermatol
, vol.112
, pp. 370-375
-
-
Yu, W.H.1
Kashani-Sabet, M.2
Liggitt, D.3
Moore, D.4
Heath, T.D.5
Debs, R.J.6
-
25
-
-
2942733462
-
Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes
-
Lee EH, Kim A, Oh YK, Kim CK. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 2005; 26: 205-210.
-
(2005)
Biomaterials
, vol.26
, pp. 205-210
-
-
Lee, E.H.1
Kim, A.2
Oh, Y.K.3
Kim, C.K.4
-
26
-
-
0034007723
-
Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex
-
Domashenko A, Gupta S, Cotsarelis G. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol 2000; 18: 420-423.
-
(2000)
Nat Biotechnol
, vol.18
, pp. 420-423
-
-
Domashenko, A.1
Gupta, S.2
Cotsarelis, G.3
-
27
-
-
0033993424
-
Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposomeplasmid DNA complexes
-
BirchallJC, MarichalC, CampbellL, AlwanA, HadgraftJ, Gumbleton M. Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposomeplasmid DNA complexes. Int J Pharm 2000; 197: 233-238.
-
(2000)
Int J Pharm
, vol.197
, pp. 233-238
-
-
Birchall, J.C.1
Marichal, C.2
Campbell, L.3
Alwan, A.4
Hadgraft, J.5
Gumbleton, M.6
-
28
-
-
0142165039
-
In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome
-
Kim A, Lee EH, Choi SH, Kim CK. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 2004; 25: 305-313.
-
(2004)
Biomaterials
, vol.25
, pp. 305-313
-
-
Kim, A.1
Lee, E.H.2
Choi, S.H.3
Kim, C.K.4
-
29
-
-
0026570723
-
Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines?
-
Baker BS, Brent L, Valdimarsson H, et al. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol 1992; 126: 105-110.
-
(1992)
Br J Dermatol
, vol.126
, pp. 105-110
-
-
Baker, B.S.1
Brent, L.2
Valdimarsson, H.3
-
30
-
-
0027272228
-
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
-
Rapoport MJ, Jaramillo A, Zipris D, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87-99.
-
(1993)
J Exp Med
, vol.178
, pp. 87-99
-
-
Rapoport, M.J.1
Jaramillo, A.2
Zipris, D.3
-
31
-
-
13644257864
-
Skin permeation, biodistribution, and expression of topically applied plasmid DNA
-
Kang MJ, Kim CK, Kim MY, et al. Skin permeation, biodistribution, and expression of topically applied plasmid DNA. J Gene Med 2004; 6: 1238-1246.
-
(2004)
J Gene Med
, vol.6
, pp. 1238-1246
-
-
Kang, M.J.1
Kim, C.K.2
Kim, M.Y.3
-
32
-
-
0036281758
-
Targeted gene delivery to skin cells in vivo: A comparative study of liposomes and polymers as delivery vehicles
-
Raghavachari N, Fahl WE. Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles. J Pharm Sci 2002; 91: 615-622.
-
(2002)
J Pharm Sci
, vol.91
, pp. 615-622
-
-
Raghavachari, N.1
Fahl, W.E.2
-
33
-
-
0035850976
-
Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses
-
Liu LJ, Watabe S, Hamajima K, et al. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses. Vaccine 2001; 20: 42-48.
-
(2001)
Vaccine
, vol.20
, pp. 42-48
-
-
Liu, L.J.1
Watabe, S.2
Hamajima, K.3
-
34
-
-
0026058168
-
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation
-
Groves RW, Allen MH, Barker JN, Haskard DO, MacDonald DM. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124: 117-123.
-
(1991)
Br J Dermatol
, vol.124
, pp. 117-123
-
-
Groves, R.W.1
Allen, M.H.2
Barker, J.N.3
Haskard, D.O.4
MacDonald, D.M.5
-
35
-
-
0027190681
-
Vascular cell adhesion molecule-1: Expression in normal and diseased skin and regulation in vivo by interferon gamma
-
Groves RW, Ross EL, Barker JN, MacDonald DM. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993; 29: 67-72.
-
(1993)
J Am Acad Dermatol
, vol.29
, pp. 67-72
-
-
Groves, R.W.1
Ross, E.L.2
Barker, J.N.3
MacDonald, D.M.4
-
36
-
-
0024477696
-
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor
-
Griffiths CE, Voorhees JJ, Nickoloff BJ. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989; 20: 617-629.
-
(1989)
J Am Acad Dermatol
, vol.20
, pp. 617-629
-
-
Griffiths, C.E.1
Voorhees, J.J.2
Nickoloff, B.J.3
-
37
-
-
28244454160
-
The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment
-
Yazici AC, Tursen U, Apa DD, et al. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment. Arch Dermatol Res 2005; 297: 249-255.
-
(2005)
Arch Dermatol Res
, vol.297
, pp. 249-255
-
-
Yazici, A.C.1
Tursen, U.2
Apa, D.D.3
|